Bacterial pneumonia among HIV-infected patients: Decreased risk after tobacco smoking cessation. ANRS CO3 aquitaine cohort, 2000-2007

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Bénard, Antoine ^a,b,c   Mercié, Patrick ^a,b,c   Alioum, Ahmadou ^a,b   Bonnet, Fabrice ^a,b,c   Lazaro, Estibaliz ^c   Dupon, Michel ^c   Neau, Didier ^a,b,c   Dabis, François ^a,b,c   Chêne, Geneviève ^a,b,c,e   Dabis, F ^d,e   Dupon, M ^d,f   Longy Boursier, M ^d   Morlat, P ^d,f   Pellegrin, J L ^d,f   Ragnaud, J M ^d,f   Bruyand, M ^e   Lawson Ayayi, S ^e   Thiebaut R ^e   Bonarek, M ^f   Bonnal, F ^f   Bonnet, F ^f   Bernard, N ^f   Caubet, O ^f   Caunegre L ^f   Cazanave, C ^f   Ceccaldi, J ^f   Dauchy, F A ^f   De La Taille, C ^f   De Witte, S ^f   Duffau, P ^f   Dutronc, H ^f   Farbos, S ^f   Gemain, M C ^f   Greib, C ^f   Lacoste, D ^f   Lafarie Castet, S ^f   Loste, P ^f   Malvy, D ^f   Mercie P ^f   Neau, D ^f   Ochoa, A ^f   Tchamgoue S ^f   Viallard, J F ^f   Blanco, P ^g   Moreau, J F ^g   Pellegrin, I ^g   Fleury, H ^h   Lafon, M E ^h   Masquelier, B ^h   Breilh, D ⁱ   Miremont Salame G ^j   Blaizeau, M J ^k   Decoin, M ^k   Delveaux, S ^k   Gillet, S ^k   Hannapier, C ^k   Leleux, O ^k   Uwamaliya Nziyumvira, B ^k   Geffard, S ^l   Palmer, G ^l   Touchard, D ^l   more..

^a Centre of Clinical Investigation Clinical Epidemiology   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d Scientific Committee

^e Epidemiology and Methodology

^f Infectious Diseases and Internal Medicine   (United States)

^g Immunology

^h Virology

ⁱ Pharmacology

^j Pharmacovigilance

^k Data Collection

^l Data Management

more..

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; ARTICLE; BACTERIAL PNEUMONIA; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING; SMOKING CESSATION; VIRUS LOAD; VIRUS TRANSMISSION;

BACTERIA (MICROORGANISMS); NICOTIANA TABACUM;

EID: 84868185958     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008896     Document Type: Article

References (33)

1. Bonnet F, Chene G, Thiebaut R, Dupon M, Lawson-Ayayi S, et al. (2007) Trends and determinants of severe morbidity in HIV-infected patients: the ANRS CO3 Aquitaine Cohort, 2000-2004. HIV Med 8: 547-554.
2. Lewden C, May T, Rosenthal E, Burty C, Bonnet F, et al. (2008) Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005: The "Mortalite 2000 and 2005" Surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr 48: 590-598.
3. Arcavi L, Benowitz NL (2004) Cigarette smoking and infection. Arch Intern Med 164: 2206-2216.
4. Nuorti JP, Butler JC, Farley MM, Harrison LH, McGeer A, et al. (2000) Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med 342: 681-689.
5. Benard A, Tessier JF, Rambeloarisoa J, Bonnet F, Fossoux H, et al. (2006) HIV infection and tobacco smoking behaviour: prospects for prevention? ANRS CO3 Aquitaine Cohort, 2002. Int J Tuberc Lung Dis 10: 378-383.
6. Friis-Moller N, Weber R, Reiss P, Thiebaut R, Kirk O, et al. (2003) Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study. AIDS 17: 1179-1193.
7. World Health Organization, regional office for Europe (available at URL: http://data.euro.who.int/tobacco/?TabID=93302) [Access date: July 13th, 2009].
8. Crothers K, Griffith TA, McGinnis KA, Rodriguez-Barradas MC, Leaf DA, et al. (2005) The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med 20: 1142-1145.
9. Gordin FM, Roediger MP, Girard PM, Lundgren JD, Miro JM, et al. (2008) Pneumonia in HIV-infected persons: increased risk with cigarette smoking and treatment interruption. Am J Respir Crit Care Med 178: 630-636.
10. Le Moing V, Rabaud C, Journot V, Duval X, Cuzin L, et al. (2006) Incidence and risk factors of bacterial pneumonia requiring hospitalization in HIV-infected patients started on a protease inhibitor-containing regimen. HIV Med 7: 261-267.
11. Bruyand M, Thiebaut R, Lawson-Ayayi S, Joly P, Sasco AJ, et al. (2009) Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort. Clin Infect Dis 49: 1109-1116.
12. Beck JM, Rosen MJ, Peavy HH (2001) Pulmonary complications of HIV infection. Report of the Fourth NHLBI Workshop. Am J Respir Crit Care Med 164: 2120-2126.
13. Clarke JR, Robinson DS, Coker RJ, Miller RF, Mitchell DM (1995) AIDS and the lung: update 1995. 4. Role of the human immunodeficiency virus within the lung. Thorax 50: 567-576.
14. Wewers MD, Diaz PT, Wewers ME, Lowe MP, Nagaraja HN, et al. (1998) Cigarette smoking in HIV infection induces a suppressive inflammatory environment in the lung. Am J Respir Crit Care Med 158: 1543-1549.
15. Thiebaut R, Morlat P, Jacqmin-Gadda H, Neau D, Mercie P, et al. (2000) Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatment. Groupe d'Epidemiologie du SIDA en Aquitaine (GECSA). AIDS 14: 971-978.
16. Hackam DG, Mamdani M, Li P, Redelmeier DA (2006) Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Lancet 367: 413-418.
17. van de Garde EM, Hak E, Souverein PC, Hoes AW, van den Bosch JM, et al. (2006) Statin treatment and reduced risk of pneumonia in patients with diabetes. Thorax 61: 957-961.
18. Hirschtick RE, Glassroth J, Jordan MC, Wilcosky TC, Wallace JM, et al. (1995) Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med 333: 845-851.
19. Bouhnik AD, Chesney M, Carrieri P, Gallais H, Moreau J, et al. (2002) Nonadherence among HIV-infected injecting drug users: the impact of social instability. J Acquir Immune Defic Syndr 31 Suppl 3: S149-153.
20. Benard A, Bonnet F, Tessier JF, Fossoux H, Dupon M, et al. (2007) Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort. AIDS Patient Care STDS 21: 458-468.
21. Duval X, Baron G, Garelik D, Villes V, Dupre T, et al. (2008) Living with HIV, antiretroviral treatment experience and tobacco smoking: results from a multisite cross-sectional study. Antivir Ther 13: 389-397.
22. Tetrault JM, Crothers K, Moore BA, Mehra R, Concato J, et al. (2007) Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch Intern Med 167: 221-228.
23. Dray-Spira R, Lert F (2007) Living and working with HIV in France in 2003: results from the ANRS-EN12-VESPA Study. Aids 21 Suppl 1: S29-36.
24. Joy R, Druyts EF, Brandson EK, Lima VD, Rustad CA, et al. (2008) Impact of neighborhood-level socioeconomic status on HIV disease progression in a universal health care setting. J Acquir Immune Defic Syndr 47: 500-505.
25. Twigg HL 3rd, Spain BA, Soliman DM, Bowen LK, Heidler KM, et al. (1996) Impaired IgG production in the lungs of HIV-infected individuals. Cell Immunol 170: 127-133.
26. Burns DN, Hillman D, Neaton JD, Sherer R, Mitchell T, et al. (1996) Cigarette smoking, bacterial pneumonia, and other clinical outcomes in HIV-1 infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 13: 374-383.
27. Sullivan JH, Moore RD, Keruly JC, Chaisson RE (2000) Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients with advanced HIV infection. Am J Respir Crit Care Med 162: 64-67.
28. Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, et al. (2009) Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 360: 1815-1826.
29. Sterne JA, May M, Costagliola D, de Wolf F, Phillips AN, et al. (2009) Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 373: 1352-1363.
30. Lesprit P, Pedrono G, Molina JM, Goujard C, Girard PM, et al. (2007) Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults. Aids 21: 2425-2434.
31. Rodriguez-Barradas MC, Goulet J, Brown S, Goetz MB, Rimland D, et al. (2008) Impact of pneumococcal vaccination on the incidence of pneumonia by HIV infection status among patients enrolled in the Veterans Aging Cohort 5-Site Study. Clin Infect Dis 46: 1093-1100.
32. Pittet LA, Hall-Stoodley L, Rutkowski MR, Harmsen AG (2009) Influenza Virus Infection Decreases Tracheal Mucociliary Velocity and Clearance of Streptococcus Pneumoniae. Am J Respir Cell Mol Biol.
33. Kunisaki KM, Janoff EN (2009) Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 9: 493-504.